Log In
Print this Print this

Aerinaze, desloratadine and pseudoephedrine

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionCombination of desloratadine and pseudoephedrine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationRhinitis
Indication DetailsTreat seasonal allergic rhinitis (SAR) accompanied by nasal congestion
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today